Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Possibly Marketed Outside US

6

Other

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Glutamate NMDA receptor

3

Glycine receptor

3

Signal transducer and activator of transcription 3

3

Sodium- and chloride-dependent glycine transporter 1

3

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Phase II

3

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1980

3

1994

3

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Depression

3

Myocardial ischemia

3

Schizophrenia

3

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Preventing

3

Primary

3

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

3

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Knorr, L.

3

Von Liebig, J.

3

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

7

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

7

EPA CompTox

7

FDA UNII

7

PUBCHEM

7

ECHA (EC/EINECS)

6

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

4

Principal Form

3

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 7 of 7 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

2-(METHYLAMINO)ETHANOL

ZMQ4G4V497

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

SARCOSINE

Z711V88R5F

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1994

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Glycine receptor

Glutamate NMDA receptor

Sodium- and chloride-dependent glycine transporter 1

Conditions:

Sarcosine, also known as N-methylglycine, is a metabolite of glycine. It shares properties with both glycine and D-serine, though its effects are weaker. Sarcosine supplementation can be used to alleviate symptoms of depression and schizophrenia, or ...

improve cognition. It is absorbed more reliably by the body than D-serine, which can also treat similar conditions. Sarcosine is being investigated for its connection to prostate cancer. It may be a biomarker for prostate cancer, which means that if sarcosine levels in the blood are higher than normal, it could be an indicator of prostate cancer. This doesn’t mean that sarcosine itself causes cancer. More research is needed to confirm this relationship. Sarcosine’s main mechanism involves inhibiting a transporter, called GlyT1, which takes up glycine and D-serine into cells. This increases the levels of glycine and D-serine in the body and increases their effects. Sarcosine, a glycine transporter type 1 inhibitor and an N-methyl-D-aspartate (NMDA) receptor co-agonist at the glycine binding site, potentiates NMDA receptor function. Sarcosine is an inhibitory glycine receptor agonist.

MONOETHANOLAMINE

5KV86114PT

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1980

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Signal transducer and activator of transcription 3

Conditions:

Myocardial ischemia

Monoethanolamine is both a primary amine and a primary alcohol. It is an olamine derivative. Monoethanolamine occurs in every cell in the human body as the head group of Phosphatidylethanolamine. Monoethanolamine is a component of glycosylphosphatidy...

linositol-anchored proteins, which are essential for viability. Other sources of monoethanolamine or phosphoethanolamine in the human body are the degradation of sphingosine phosphate by sphingosine phosphate lyase and the degradation of the endocannabinoid anandamide by the fatty acid amine hydrolase. Monoethanolamine stimulates the rapid growth of mammalian cells in culture. Monoethanolamine has a cardioprotective role against ischemia/reperfusion injury via activation of the transcription factor STAT-3. Monoethanolamine is a chemical intermediate in the manufacture of cosmetics, surface-active agents, emulsifiers, pharmaceuticals, and plasticizing agents.

SARCOSINE HYDROCHLORIDE

W50V8R1ZE9

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1994

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Glycine receptor

Glutamate NMDA receptor

Sodium- and chloride-dependent glycine transporter 1

Conditions:

Sarcosine, also known as N-methylglycine, is a metabolite of glycine. It shares properties with both glycine and D-serine, though its effects are weaker. Sarcosine supplementation can be used to alleviate symptoms of depression and schizophrenia, or ...

improve cognition. It is absorbed more reliably by the body than D-serine, which can also treat similar conditions. Sarcosine is being investigated for its connection to prostate cancer. It may be a biomarker for prostate cancer, which means that if sarcosine levels in the blood are higher than normal, it could be an indicator of prostate cancer. This doesn’t mean that sarcosine itself causes cancer. More research is needed to confirm this relationship. Sarcosine’s main mechanism involves inhibiting a transporter, called GlyT1, which takes up glycine and D-serine into cells. This increases the levels of glycine and D-serine in the body and increases their effects. Sarcosine, a glycine transporter type 1 inhibitor and an N-methyl-D-aspartate (NMDA) receptor co-agonist at the glycine binding site, potentiates NMDA receptor function. Sarcosine is an inhibitory glycine receptor agonist.

SODIUM SARCOSINATE

6EHN3PQL8Z

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1994

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Glycine receptor

Glutamate NMDA receptor

Sodium- and chloride-dependent glycine transporter 1

Conditions:

Sarcosine, also known as N-methylglycine, is a metabolite of glycine. It shares properties with both glycine and D-serine, though its effects are weaker. Sarcosine supplementation can be used to alleviate symptoms of depression and schizophrenia, or ...

improve cognition. It is absorbed more reliably by the body than D-serine, which can also treat similar conditions. Sarcosine is being investigated for its connection to prostate cancer. It may be a biomarker for prostate cancer, which means that if sarcosine levels in the blood are higher than normal, it could be an indicator of prostate cancer. This doesn’t mean that sarcosine itself causes cancer. More research is needed to confirm this relationship. Sarcosine’s main mechanism involves inhibiting a transporter, called GlyT1, which takes up glycine and D-serine into cells. This increases the levels of glycine and D-serine in the body and increases their effects. Sarcosine, a glycine transporter type 1 inhibitor and an N-methyl-D-aspartate (NMDA) receptor co-agonist at the glycine binding site, potentiates NMDA receptor function. Sarcosine is an inhibitory glycine receptor agonist.

ETHANOLAMINE HYDROFLUORIDE

6UT951O512

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1980

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Signal transducer and activator of transcription 3

Conditions:

Myocardial ischemia

Monoethanolamine is both a primary amine and a primary alcohol. It is an olamine derivative. Monoethanolamine occurs in every cell in the human body as the head group of Phosphatidylethanolamine. Monoethanolamine is a component of glycosylphosphatidy...

linositol-anchored proteins, which are essential for viability. Other sources of monoethanolamine or phosphoethanolamine in the human body are the degradation of sphingosine phosphate by sphingosine phosphate lyase and the degradation of the endocannabinoid anandamide by the fatty acid amine hydrolase. Monoethanolamine stimulates the rapid growth of mammalian cells in culture. Monoethanolamine has a cardioprotective role against ischemia/reperfusion injury via activation of the transcription factor STAT-3. Monoethanolamine is a chemical intermediate in the manufacture of cosmetics, surface-active agents, emulsifiers, pharmaceuticals, and plasticizing agents.

ETHANOLAMINE HYDROCHLORIDE

KKP3YYL02F

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1980

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Signal transducer and activator of transcription 3

Conditions:

Myocardial ischemia

Monoethanolamine is both a primary amine and a primary alcohol. It is an olamine derivative. Monoethanolamine occurs in every cell in the human body as the head group of Phosphatidylethanolamine. Monoethanolamine is a component of glycosylphosphatidy...

linositol-anchored proteins, which are essential for viability. Other sources of monoethanolamine or phosphoethanolamine in the human body are the degradation of sphingosine phosphate by sphingosine phosphate lyase and the degradation of the endocannabinoid anandamide by the fatty acid amine hydrolase. Monoethanolamine stimulates the rapid growth of mammalian cells in culture. Monoethanolamine has a cardioprotective role against ischemia/reperfusion injury via activation of the transcription factor STAT-3. Monoethanolamine is a chemical intermediate in the manufacture of cosmetics, surface-active agents, emulsifiers, pharmaceuticals, and plasticizing agents.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1